• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Reimbursement Top Challenge for Labs in 2025

Reimbursement Top Challenge for Labs in 2025

by Rachel Muenz | Jan 23, 2025 | Essential, Inside the Lab Industry-lir, Lab Industry Advisor

ACLA president Susan Van Meter discusses some of the key issues labs faced in 2024, along with work to address these developments through 2025

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Which Recent FDA Webinars Are Most Useful for the LDT Rule?

Which Recent FDA Webinars Are Most Useful for the LDT Rule?

by Tara Cepull, MA | Jan 22, 2025 | Compliance Perspectives-lca, Essential, FDA-lca, Lab Industry Advisor

Regulatory expert Julie Ballard shares her thoughts on the most useful resources for labs as they get ready to comply with Stage 1

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?

FDA Watch: How Could the Change in US Government Affect IVDs and Labs?

by Rachel Muenz | Jan 6, 2025 | Essential, FDA-lir, Lab Industry Advisor

Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Testing for Intestinal Parasites Takes Step Forward

Diagnostics Pipeline: Testing for Intestinal Parasites Takes Step Forward

by Ron Shinkman | Nov 25, 2024 | Clinical Diagnostics Insider, FDA-dtet

The EasyScreen assay received 510(k) clearance from the Food and Drug Administration earlier this year–but with a catch

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule

Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule

by Rachel Muenz | Nov 21, 2024 | Compliance Perspectives-lca, FDA-lca, Lab Industry Advisor, Premium

Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com